Brazilian federal authorities are investigating an Argentine scientist for the alleged theft of 24 high-risk viral strains from the State University of Campinas (Unicamp) in São Paulo. The case, which has raised concerns about biosafety protocols in Latin America, involves the unauthorized removal of pathogens from maximum-security laboratories.
Soledad Palameta Miller, 36, was detained on March 23, 2026, following a coordinated effort between the university, the Federal Police, and the National Health Surveillance Agency (Anvisa). The investigation centers on the movement of sensitive biological material and whether these samples were intended for private commercial gain.
The stolen materials are classified under Biosafety Level 3 (BSL-3), a designation reserved for indigenous or exotic agents that may cause serious or potentially lethal disease through inhalation. The recovered list of pathogens includes strains of dengue, zika, chikungunya, coronavirus, Epstein-Barr, herpes, and influenza variants such as H1N1 and H3N9.
As a physician, I recognize that BSL-3 materials require specialized ventilation, rigorous PPE, and strict containment to prevent accidental release. While authorities state the recovered samples were found sealed and frozen—meaning there was no immediate public health crisis—the breach of security at a premier research institution highlights a significant vulnerability in the chain of custody for dangerous pathogens.
The Timeline of the Breach
The investigation began after Unicamp officials noticed the disappearance of biological samples from their high-security virology labs. Security footage became a cornerstone of the evidence, showing Palameta Miller and her husband, Brazilian veterinarian Michael Edward Miller, entering the laboratories during irregular hours starting in November 2025.
Investigators believe the couple systematically moved the viral strains from the secure virology wing to freezers located within the Faculty of Food Engineering. This relocation was an unauthorized move of hazardous materials into a facility not equipped or permitted to handle high-risk pathogens.
| Date/Period | Event |
|---|---|
| May 2025 | Founding of Agrotrix Brasil LTDA by the couple. |
| Nov 2025 | Security footage records irregular lab entries. |
| March 2026 | Unicamp notifies Federal Police and Anvisa. |
| March 23, 2026 | Detention of Soledad Palameta Miller. |
Adding to the gravity of the case, authorities detected that Palameta entered another laboratory between March 21 and March 23, continuing her activities even after the initial raids had commenced. This suggests a persistent attempt to access or remove materials despite the ongoing law enforcement operation.
Commercial Interests and Agrotrix Brasil
A primary line of inquiry for the Federal Police is whether the 24 viral strains were intended for sale or the development of proprietary medical products. Investigators are focusing on Agrotrix Brasil LTDA, a startup founded by the couple in May 2025 with minimal initial capital.
The startup officially offered research and development services in natural sciences, agronomy, and veterinary medicine. However, Unicamp has clarified that Agrotrix was only authorized to operate within a coworking space; the company had no legal permit or facility certification to manipulate biological material of any kind.
This discrepancy suggests that the university’s infrastructure may have been used as a covert laboratory for a private venture, bypassing the rigorous ethical and safety reviews required for BSL-3 research. The Faculty of Food Engineering has since formally distanced itself from the scientist, emphasizing that the handling of high-risk pathogens was never part of the authorized functions of that department.
Legal Implications and Defense
Palameta Miller currently faces severe charges under Brazilian law, including qualified theft, procedural fraud, and the irregular transport of biological material. Due to the sensitive nature of the evidence, the Federal Court of Campinas has placed the case under segredo de sumario (judicial secrecy), restricting public access to the full case files.
Her defense attorney, Pedro de Mattos Russo, has stated that he will not provide further declarations at this time, citing the court-ordered secrecy. Meanwhile, Unicamp has initiated internal administrative proceedings that could lead to the scientist’s permanent expulsion from the institution.
Public Health Risks and Biosafety Standards
The theft of 24 viral strains, including those associated with the COVID-19 pandemic and mosquito-borne illnesses like Zika and Dengue, represents a theoretical risk of accidental exposure. In a laboratory setting, these viruses are kept in specialized containers and handled in biosafety cabinets to ensure they do not enter the environment.
The risk to the broader Latin American region is mitigated by the fact that the samples were found frozen and sealed. However, the incident underscores the “insider threat” in scientific research—where individuals with legitimate access utilize their credentials to bypass security for illicit purposes.
For the scientific community, this case serves as a reminder that physical security (locks and cameras) must be paired with rigorous biological auditing. When high-risk strains are moved without a documented paper trail, the window for detection can be months, as seen in this instance where activity began in late 2025 but was not halted until March 2026.
Disclaimer: This article is for informational purposes and does not constitute legal or medical advice.
The next critical step in the legal process will be the review of the evidence by the Federal Court of Campinas to determine if formal indictments will lead to a trial. Further updates are expected as the judicial secrecy period evolves and the university concludes its administrative hearing.
We invite readers to share their thoughts on biosafety regulations in the comments section below.
